AUXELBI (Class 5)

The trademark application number 6303092 is currently marked as "Accepted & Advertised" in the official trademark registry.

The trademark application number 6303092 is owned by Novartis AG.

Trademark application number 6303092 is filed under Class 5, which relates to the specified goods and services.

Yes, trademark application number 6303092 was published in Journal No. 2183.

Trademark application number 6303092 relates to "[CLASS : 5] Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of dermatological diseases; pharmaceutical preparations for the prevention and treatment of rheumatological diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of central nervous system diseases; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases of the auto-immune system; pharmaceutical preparations for the prevention and treatment of diseases of the metabolic system; pharmaceutical preparations for the prevention and treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention and treatment of diseases of the musculo-skeletal system; pharmaceutical preparations for the prevention and treatment of diseases of the genitourinary system; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of cancers; pharmaceutical preparations for the prevention and treatment of tumors; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases.".